Drug
Nxt007
Nxt007: highest development phase Phase 3, developed by Roche. 4 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| NXT007 NCT07416604 | Phase 3 | Hemophilia A |
| NXT007 NCT07416526 | Phase 3 | Hemophilia A |
| NXT007 NCT07838194 | Phase 3 | Hemophilia A |
| NXT007 NCT05987449 | Phase 1/2 | Hemophilia A |
Latest
No recent events.
Follow Nxt007 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.